Chugai Pharmaceutical Co (MEX:4519N) Cyclically Adjusted Book per Share: MXN87.24 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4519N Chugai Pharmaceutical Co Ltd MEX:4519N
94 GF Score
Price MXN732.85
GF Value MXN848.07
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Chugai Pharmaceutical Co Cyclically Adjusted Book per Share?

Chugai Pharmaceutical Co MEX:4519N 94 Cyclically Adjusted Book per Share is MXN87.24 as of Jun. 2026. GuruFocus rates MEX:4519N with a GF Score™ of 94/100 and a GF Value™ of MXN848.07 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Chugai Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was MXN133.734. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN87.24 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Chugai Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 12.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 14.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Chugai Pharmaceutical Co was 14.90% per year. The lowest was 6.70% per year. And the median was 11.60% per year.

As of today (2026-09-05), Chugai Pharmaceutical Co's current stock price is MXN732.85. Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN87.24. Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 8.40.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Chugai Pharmaceutical Co was 15.27. The lowest was 4.33. And the median was 8.86.


Chugai Pharmaceutical Co  (MEX:4519N) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=732.85/87.24
=8.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Chugai Pharmaceutical Co was 15.27. The lowest was 4.33. And the median was 8.86.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Chugai Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Chugai Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chugai Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 85.06 60.98 79.89 71.89

Chugai Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.71 88.70 71.89 86.06 87.24

MEX:4519N vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


MEX:4519N
94GF Score
Chugai Pharmaceutical Co Ltd MEX:4519N
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chugai Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chugai Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=133.734/113.6000*113.6000
=133.734

Current CPI (Jun. 2026) = 113.6000.

Chugai Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 73.109 98.000 84.747
201612 70.008 98.400 80.822
201703 65.833 98.100 76.235
201706 66.394 98.500 76.572
201709 67.355 98.800 77.445
201712 73.351 99.400 83.830
201803 74.167 99.200 84.933
201806 79.579 99.200 91.131
201809 75.173 99.900 85.482
201812 80.574 99.700 91.807
201903 80.846 99.700 92.117
201906 85.769 99.800 97.629
201909 90.928 100.100 103.191
201912 89.875 100.500 101.590
202003 113.244 100.300 128.260
202006 118.339 99.900 134.568
202009 117.853 99.900 134.015
202012 114.251 99.300 130.704
202103 112.406 99.900 127.821
202106 115.702 99.500 132.098
202109 123.838 100.100 140.539
202112 130.203 100.100 147.763
202203 126.679 101.100 142.342
202206 119.401 101.800 133.241
202209 111.725 103.100 123.103
202212 125.178 104.100 136.602
202303 117.844 104.400 128.229
202306 111.618 105.200 120.530
202309 109.985 106.200 117.649
202312 116.478 106.800 123.894
202403 110.551 107.200 117.151
202406 123.544 108.200 129.710
202409 150.784 108.900 157.292
202412 156.682 110.700 160.787
202503 159.078 111.100 162.658
202506 157.199 111.700 159.873
202509 142.487 112.000 144.523
202512 142.151 113.000 142.906
202603 131.728 112.700 132.780
202606 133.734 113.600 133.734

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN87.24 mean?
Chugai Pharmaceutical Co (MEX:4519N) has a Cyclically Adjusted Book per Share of MXN87.24 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Chugai Pharmaceutical Co and its competitors.
Is Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Chugai Pharmaceutical Co's current Cyclically Adjusted Book per Share is MXN87.24. Overall, Chugai Pharmaceutical Co has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share compare to LLY and JNJ?
Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share of MXN87.24 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Chugai Pharmaceutical Co and its competitors. Chugai Pharmaceutical Co's current Cyclically Adjusted Book per Share is MXN87.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chugai Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Chugai Pharmaceutical Co (MEX:4519N) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN848.07, compared to a current price of MXN732.85 — trading 13.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is MXN87.24. Chugai Pharmaceutical Co's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Chugai Pharmaceutical Co (MEX:4519N), the current Cyclically Adjusted Book per Share is MXN87.24 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chugai Pharmaceutical Co (MEX:4519N) Overvalued in 2026?

Based on GuruFocus' analysis, Chugai Pharmaceutical Co stock appears to be undervalued. The current stock price of MXN732.85 is trading 13.6% below its estimated GF Value™ of MXN848.07. GuruFocus considers Chugai Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for MEX:4519N:

  • Cyclically Adjusted Book per Share: MXN87.24
  • GF Value™: MXN848.07 vs. price of MXN732.85 (13.6% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the MEX:4519N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chugai Pharmaceutical Co Business Description

Address 2-1-1 Muromachi, Nihonbashi, 12th Floor, Nihonbashi Mitsui Tower, Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).
94GF Score

Get the complete analysis for MEX:4519N

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN732.85
Price
MXN848.07
GF Value